Isoflavonoids — an overview of their biological activities and potential health benefits
There are many biological activities attributed to isoflavonoids. The majority of them could be beneficial and some of them may be detrimental, depending on specific circumstances. Isoflavonoids play an important role in human nutrition as health promoting natural chemicals. They belong to plant secondary metabolites that mediate diverse biological functions through numerous pathways. They are structurally similar to estrogens, exerting both estrogenic and antiestrogenic properties in various tissues. The results of epidemiologic studies exploring the role of isoflavonoids in human health have been inconclusive. Some studies support the notion of a protective effect of their consumption in immunomodulation, cognition, risk reduction of certain cancers, cardiovascular and skin diseases, osteoporosis and obesity, as well as relief of menopausal symptoms. Other studies failed to demonstrate any effects.
Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S. (2008). Dietary soy isoflavone intake and risk of colorectal cancer in the Japan Public Health Cancer-based prospective study. Epidem Biomark Prev17 (8): 2128-2135.
Atkinson C, Warren RM, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA. (2004). Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial. Breast Can Res6 (3): 170-179.
Barnes S. (2004). Soy isoflavones - phytoestrogens and what else? J Nut134: 1225S-1228S.
Bezek S, Ujhazy E, Mach M, Navarova J, Dubovicky M. (2008). Developmental origin of chronic diseases: toxicological implication. Interdisc Toxicol1 (1): 29-31.
Birt DF, Hendrich S, Wang W. (2001). Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther90 (2-3): 157-177.
Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G. (2005). N-Acetyltransferase 2 status and gastric cancer risk: a preliminary meta-analysis. Ital J Pub Health2: 53-57.
Cesarone MR, Grossi MG, Di Renzo, A, Errich S, Schönlau F, Wilmer JL, Lange M, Blimenfeld J. (2009). Accelerated antioxidant bioavailability of OPC-3® bioflavonoids administered as isotonic solution. Phytother Res23 (6): 775-777.
Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H. (2008). Estrogen-biosynthesis gene CYP17 and its interactions with reproductive hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogen29 (4): 766-771.
Cherdshewasart W, Sutjit W. (2008). Correlation of antioxidant activity and major isoflavonoid contents of the phytoestrogen-rich Pueraria mirifica and Pueraria libata tubers. Phytomed15 (1-2): 38-43.
Chodon D, Ramamurty N, Sakthisekan D. (2007). Inhibition of cell proliferation and induction of apoptosis by genistein in hepatocellular carcinoma. Tox in Vitro20 (5): 887-891.
Chrzan BG, Bradford PG. (2007). Phytoestrogens activate estrogen receptor β1 and estrogenic responses in human breast and bone cancer cell lines. Mol Nutr Food Res51: 171-177.
Dixon RA, Summer LW. (2003.) Legume natural products: Understanding and manipulating complex pathways for human and animal health. Plant Physiol131: 878-885.
Duffy C, Perez K, Partridge A. (2007). Implications of phytoestrogen intake for breast cancer. CA Can J Clin57: 260-277.
Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE. (2008). Circulating 2-hydroxy and 16a-hydroxy estrone levels and risk of breast cancer among post-menopausal women. Can Epidem Biomark Prev17 (8): 2029-2035.
Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teiltelbaum SL, Neugut AI, Gammon MD. (2007). Dietary flavonoid intake and breast cancer survival among women on Long Island. Can Epidem Biomark Prev16: (11): 2285-2292.
Goodman MT, Shvetsov YB, Wilkens LR, Franke AA, Marchand LL, Kazaku KK, Nomura AMY, Henderson BE, Kolonel LN. (2009). Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study. Can Prev Res2: 887.
Hirschberg AL, Edlund M, Svane G, Azavedo E, Skoog L, von Schoultz B. (2007). An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause14 (1): 89-96.
Hedlund TE, van Bokhaven A, Johannes WU, Nordeen SK, Ogden LG. (2005) Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant epithelial cells in vitro.The Prost66 (5): 557-566.
Ito C, Murata T, Itoigawa M, Nakao K, Kumagai M, Kaneda N, Furukawa H. (2006). Induction of apoptosis by isoflavonoids from leaves of Milletia taiwaniana in human leukemia HL-60 cells. Planta Med72 (5): 424-429.
Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurashi N, Miura T, Yamoto S, Tsugane S. (2008). Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from Japan Public Health Center-base prospective study group. J Clin Oncol26 (10): 1677-1683.
Ju IH, Allred KF, Allred CD, Helferich WG. (2006). Genistein stimulates growth of human breast cancer cells in a novel postmenopausal animal model, with low plasma estradiol concentrations. Carcinogen27: 1292-1299.
Kousidou OC, Tzanakakis GN, Karamanos NK. (2006). Effects of natural isoflavonoid genistein on growth, signaling pathway and gene expression of matrix macromolecules by breast cancer cells. Mini Rev Med Chem6 (3): 331-337.
Kralova J, Pekarova M, Drabikova K, Jancinova V, Nosal R, Ciz M, Lojek A. (2008). The effects of dithiaden on nitric oxide production by RAW 264.7 cells. Interdisc Toxicol1 (3-4): 214-217.
Lampe JW. (2009). Is equol the key to the efficacy of soy foods? Am J Clin Nutr89: 1664S-1667S.
Lockwood B. (2008). The beneficial effects of soy isoflavones in osteoporosis of the elderly. Elderly Nutr AgroFood Ind Hi-tech19 (5):38-41.
Liu B, Edgerton S, Yang X. (2005). Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Can Res65: 879-886.
Maskarinec G, Williams AE, Carlin L. (2003). Mammographic densities in a oneyear isoflavone intervention. Eur J Can Prev12 (2):165-169.
Maskarinec G, Hebshi S, Custer L, Franke AA. (2008a). The relation of soy intake and isoflavone levels in nipple aspirate fluid. Eu J Can Prev17(1): 67-70.
Maskarinec G, Watts K, Kagihara J, Hebshi SM, Franke AA. (2008b) Urinary isoflavonoid is similar after consuming soya milk and miso soup in Japanese-American women. Brit J Nutr100: 424-429.
Maskarinec G, Verheus M, Steinberg FM, Amato P, Cramer M, Lewis RD, Murray MJ, Yong RL, Wong WW. (2009). Various doses of isoflavones do not modify mammographic density in postmenopausal women. J Nutr139 (5): 981-986.
Messina M, Wood CE. (2008). Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J7(1): 17-28.
Messina M, McCaskill-Stevens W, Lampe JW. (2006). Addressing the soy and breast cancer relatioship: review, commentary, and workshop proceedings. J Natl Can Inst98 (18): 1275-1284.
Miadokova E, Masterova I, Vlckova V, Duhova V, Toth J. (2002). Antimutagenic potential of homoisoflavonoids from Muscari racemosum.J Ethnopharmacol18: 381-386.
Murata IC, Itoigawa M, Nakao K, Kumagai M, Kaneda N, Furukawa H. (2006). Induction of apoptosis by isoflavonoids from the leaves of Millettia taiwaniana in human leukemia HL-60 cells. Planta Med72 (5): 424-429.
Myasoedova VA, Sobenin IA. (2008). Background, rationale and design of clinical study of the effect of isoflavonoid-rich botanicals on natural history of atherosclerosis in women. Atheroscler Suppl. 9 (1): 171.
Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, Oba S, Shimizu H. (2008). Soy isoflavone intake is not associated with the development od cedar pollinosis in adults. J Nutr138: 1372-1376
Ørgaard A, Jensen L. (2008). The effects of soy isoflavones on obesity Exp Biol Med233: 1066-1080.
Perry DL, Spedick JM, McCoy TP, Adams MR, Franke AA, Cline JM. (2007). Dietary soy protein containing isoflavonoids does not adversely affect the reproductive tract of male cynomolgus macaques (Macaca fascicularis).J Nutr137: 1390-1394.
Piller R, Chang-Claude J, Linseisen J. (2006). Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eu J Can Prev15 (3): 225-232.
Raju J, Bielecki A, Caldwell D, Lok E, Taylor M, Kapal K, Curran I, Cooke GM, Bird RP, Mehta R. (2009). Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells increasing the expression of estrogen receptor beta. Nutr139 (3): 474-4781.
Ralston L, Subramanian S, Matsuto M, Yu O. (2005). Partial reconstruction of flavoid and soflavoid biosynthesis in yeast using soybean Type I and Type II chalcone isomerases. Plant Physiol137 (4): 1375-1388.
Reiter RJ, Paredes SD, Kormaz A, Jou M-J, Tan D-X. (2008). Melatonin combats molecular terrorism at the mitochondrial level Interdisc Toxicol1 (2): 137-149.
Rice S, Mason HD, Whitehead SA. (2006). Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J Ster Biochem Mol Biol101 (4-5): 216-225.
Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. (2006). Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr83: 118-1125.
Sabudak T, Guler N. (2009). Trifolium L.- A review on its phytochemical and pharmacological profile. Phytother Res23: 439-446.
Shen P, Liu MH, Ng TY, Chan YH, Long EL. (2006) Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPAR gamma, and adipocyte differentiation in vitro J Nutr136: 899-905.
Scarpato R, Paganucci L, Bertoli A, Fiore L, Pistelli L, Federico G. (2008). Licoflavone C attenuates the genotoxicity of cancer drugs in human peripheral lymphocytes. Phytother Res22 (12): 1650-1654.
Shen P, Liu MH, Ng TY, Chan YH, Yong EL. (2006). Differential effects of isoflavones, from Astragalus membranaceus and Puerarua thomsonii, on the activation of PPARalpha, PPAR gamma, and adipocyte differentiation in vitro.J Nutr136: 899-905.
Stienstra R, Duval C, Ller M, Kersten S. (2007). PPARs, obesity, and inflammation. PPAR Res. 2007: 95974.
Su Y, Simmen RCM. (2009). Soy isoflavone genistein upregulates epithelian adhesion molecule E-cadherin expression and β-catenin signaling in mammary epithelial cells. Carcinogen30 (2): 331-339.
Talbott KE, Gammon MD, Kibriva MG, Chen Y, Teilbaum SL, Long CM, Gurvich I, Santella RM, Ahsan H. (2008). A Cyp 19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk. Breast Can Res Treat111 (3): 481-487.
Tamini RM, Hankinson SE, Coldiz GA, Byrne C. (2005). Endogenous sex hormone levels and mammographic density among postmenopausal women. Can Epidem Biomark Prev14: 2641-2647.
Thorp AA, Howe PR, Mori TA, Coates AM, Buckley JD, Hodgson J, Mansour J, Meyer BJ. (2008.) Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers. Am J Clin Nutr88 (2): 298-304.
Verheus M, van Gils CH, Kreijkamp-Kaspers S, Kok L, Peeters PH, Grobbee DE, van der Schouw YT. (2008). Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Can Epidem Biomark Prev17 (10): 2632-2638.
Wang Y, Gho WM, Chan FL, Chen S, Leung LK. (2008). The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Brit J Nutr99: 303-310.
Wood CE, Appt S, Clarkson TB, Franke AA, Lees C, Doerge DR, Cline JM. (2006). Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol Rep75 (3): 477-486.
Wood CE, Register TC, Cline JM. (2007). Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys. Carcinogen28 (4): 801-808.
Widyarini S, Domanski D, Painter N, Reeve VE. (2006). Estrogen receptor signaling protects against immune suppression by UV radiation exposure. Proc Nat Acad Sci103 (34): 12837-12842.